Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Lorenz

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
TNF inhibitors in the treatment of arthritisH M Lorenz
Der Orthopade|July 4, 2012
[Rheumatoid arthritis: diagnostics and therapy 2012]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|March 28, 2013
[What's new in connective tissue diseases?]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|March 31, 2011
[Recent advances in diagnosis and treatment of connective tissue diseases]H-M Lorenz
Expert Opinion on Investigational Drugs|November 4, 2000
Biological agents: a novel approach to the therapy of rheumatoid arthritisH M Lorenz
Zeitschrift Fur Rheumatologie|November 20, 2010
[Biomarkers collections: the future or a waste of resources?]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|March 22, 2012
[Connective tissue diseases]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|September 1, 2009
[Do biologicals have a place in the treatment of collagen diseases? Pro]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|September 6, 2013
[Rheumatology and clinical immunology: cross-disciplinary fields]H-M Lorenz
Zeitschrift Fur Rheumatologie|November 11, 2010
[Regulatory B cells and their role in maintaining peripheral tolerance]T Tretter, H-M Lorenz
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
TNF inhibitors in the treatment of arthritisH M Lorenz
Der Orthopade|July 4, 2012
[Rheumatoid arthritis: diagnostics and therapy 2012]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|March 28, 2013
[What's new in connective tissue diseases?]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|March 31, 2011
[Recent advances in diagnosis and treatment of connective tissue diseases]H-M Lorenz
Expert Opinion on Investigational Drugs|November 4, 2000
Biological agents: a novel approach to the therapy of rheumatoid arthritisH M Lorenz
Zeitschrift Fur Rheumatologie|November 20, 2010
[Biomarkers collections: the future or a waste of resources?]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|March 22, 2012
[Connective tissue diseases]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|September 1, 2009
[Do biologicals have a place in the treatment of collagen diseases? Pro]H-M Lorenz
Deutsche Medizinische Wochenschrift (1946)|September 6, 2013
[Rheumatology and clinical immunology: cross-disciplinary fields]H-M Lorenz
Zeitschrift Fur Rheumatologie|November 11, 2010
[Regulatory B cells and their role in maintaining peripheral tolerance]T Tretter, H-M Lorenz
Pageof 11